TAT-Apoptin induces apoptosis in the human bladder cancer EJ cell line and regulates Bax, Bcl-2, caspase-3 and survivin expression

Experimental and Therapeutic Medicine

Volumn 3, Issue 6, 2012, Pages 1033-1038

  Li, Jun ^a   Wang, Haifeng ^a   Ma, Zhen ^a   Fan, Wenxing ^a   Li, Yanfeng ^a   Han, Bingbing ^a   Zhang, Zhijia ^a   Wang, Jiansong ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; EJ cell line; Expression; Inhibition; TAT Apoptin

Indexed keywords

APOPTIN; CASPASE 3; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN EJ; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT DURATION; TUMOR CELL LINE; WESTERN BLOTTING;

EID: 84859461410     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.520     Document Type: Article

References (16)

1. Han SX, Ma JL, Lu Y, Huang C and Duan KM: SP-TAT-Apoptin induces G1 arrest in HepG2 cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24: 864-866, 2008 (In Chinese).
2. Han SX, Zhao J, Ma JL, et al: The effect of the fused gene of SP-TAT-Apoptin transfected by lentivirus on HepG2 cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26: 310-312, 2010 (In Chinese).
3. Han SX, Zhu Q, Ma JL, et al: Apoptin sensitizes radiation-induced cell death via classic mitochondrial, caspase and p53-dependent signaling in HepG2 cells. Mol Med Report 4: 59-63, 2011.
4. Schoop RA, Baatenburg de Jong RJ and Noteborn MH: Apoptin induces apoptosis in an oral cancer mouse model. Cancer Biol Ther 7: 1368-1373, 2008.
5. Wang C and Zhang Y: Apoptin gene transfer via modified wheat histone H4 facilitates apoptosis of human ovarian cancer cells. Cancer Biother Radiopharm 26: 121-126, 2011.
6. Zhou J, Yue X, Han J and Yang W: Improved MTT assay for activity of antitumor agents. Chin J Pharmaceut 24: 455-457, 1993.
7. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) method. Methods 25: 402-408, 2001.
8. Calogero A, Arcella A, De Gregorio G, et al: The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res 7: 2788-2796, 2001.
9. Baron V, Adamson ED, Calogero A, et al: The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGF-β1, PTEN, p53, and fibronectin. Cancer Gene Ther 13: 115-124, 2006.
10. Gu FL: Changing constituents of genitourinary cancer in recent 50 years in Beijing. Chin Med J (Engl) 116: 1391-1393, 2003.
11. Pruthi RS, Baldwin N, Bhalani V and Wallen EM: Conservative management of low risk superficial bladder tumors. J Urol 179: 87-90, 2008.
12. Schulze M, Stotz N and Rassweiler J: Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach. J Endourol 21: 1533-1541, 2007.
13. Backendorf C, Visser AE, de Boer AG, et al: Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu Rev Pharmacol Toxicol 48: 143-169, 2008.
14. Rohn JL and Noteborn MHM: The viral death effector Apoptin reveals tumor-specific processes. Apoptosis 9: 315-322, 2004.
15. Zhuang SM, Shvarts A, van Ormondt H, et al: Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res 55: 486-489, 1995.
16. Schoop RA, Kooistra K, Baatenburg de Jong RJ and Noteborn MHM: Bcl-xL inhibits p53-but not apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line. Int J Cancer 109: 38-42, 2004.